GRAL was selected for funding as a Laboratoire d’excellence (Labex) through the “Investissements d’avenir” programme of the French government in 2011. GRAL’s funding has been extended until 2028 through the Chemistry, Biology and Health Graduate School of Université Grenoble Alpes.
The project is at the interface between structural and cellular biology, and is multidisciplinary by nature. Its scientists, research staff, and students conduct forefront and innovative research in structural biology, cellular biology, integrative biology, plant biology, nanobiology, pathogenic-host interactions, cancer biology, molecular chemistry…
GRAL’s priorities are to decipher and integrate knowledge on the structure and dynamics of biological molecules and their function in the cellular context, in space and time.
The integrated approaches to address biological questions at different scales of resolution, analyzing their dynamics and function in vitro and in vivo model systems, will provide important results for basic science and will open up new opportunities in health, environment, and biotechnologies.
News
GRAL PhD projects 2023-2026 (5th call)
In the framework of the Chemistry, Biology, Health Graduate School (CBH-EUR-GS) of Université Grenoble Alpes, CBH Graduate School, Arcane Labex, and GRAL Labex have launched a common call to fund PhD projects. A researcher can only apply to one of the 3 funding...
Fluorescent proteins don’t like sunburns
Super resolution microscopy continues to reveal new insights into biology at the nanoscale. Quantitative measurements using super resolution microscopy, however, remain limited due to the highly complex photophysical behavior of the used fluorescent labels. In the...
Support for technology transfer
GRAL can support the early stages of development of emerging technologies in Integrated Structural and Cell Biology (derived from academic research within GRAL labs: BioSanté, IBS, LCBM, and LPCV). Financial support from GRAL will help scientists increase the level of...
